C
915 posts

C
@CTstarski
Healthcare, Basketball, Lifting.




The NIH cancer curve just broke. As of Mar 03, NIH cancer funding is ⇣1,308 awards behind what the 5-year median should be. That’s a 57% shortfall. @Nature lit the match on this story so we dug deeper to lift the curtain specifically for cancer. If this trend holds, the effects are both immediate & long term. So many questions remain unanswered. This week we’re breaking it all down: • Which mechanisms are most delayed (R01 vs U vs P) • Which cancer areas are absorbing the hit • Which institutions are most exposed • Where it hits first: screening, trials, imaging, prevention, survivorship If you run a lab, grants office, or cancer center, tell us what cut you want. I'll send you a report for free + maybe also publish it for on here. Source: NIH RePORTER via @Jori_health





That 135 bench tweet struck a nerve with all the nerds on NFL twitter LMFAOOOO

Thanks, Ted, though I would argue that *much* of the data that sits in terminals actually cannot be replicated by Google, even if they tried. To take just one of many examples, Google or Claude can go and identify Apple's 2026 consensus EPS quite easily. That is very different than having 20+ years of broker-level estimates across 15,000+ global companies, maintained through direct data-sharing agreements with each brokerage. To get that level of clean, comprehensive data across any global ticker for $25-$30k/seat has been, and will continue to be, a no-brainer for institutional banking & investment firms. This is before we consider the true token-level cost of trying to replicate this all with Claude (and even then, won't include decades of history which is critical for both quantitative back testing and fundamental investing, alike). It seems very obvious (to me, not to the stock prices!) that AI will simply be a new distribution channel for this deep moat of institutional-grade data, not a secular threat to the terminal value. Not to mention the potential efficiency uplifts in the terminal/data provider business model. A big theme over next 9-18m in market, in my opinion, is opex/efficiency tailwind to previously staid businesses (happening at CHRW right now), and data-processing heavy businesses with 5k+ offshore data analysts & "data journalists" armed with Claude Code feels like an obvious area to consider potentially transformational efficiency improvements.



The Nets had five first round picks in the 2025 NBA Draft. Those five players combined for just 6 first half minutes against Indiana. Only one player, Egor Dëmin, played. This comes even with Cam Thomas leaving after the opening minutes with injury. Jordi Fernandez is leaning heavily on veterans as the Nets seek their first win.

How do I position myself to get a seat at a L/S fund covering software in 2/3 years? Is that possible or do I need more time or? Been on sell side for 6 months now







